Korro Bio (KRRO) Share-based Compensation (2018 - 2026)

Korro Bio's Share-based Compensation history runs 9 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• Quarterly Share-based Compensation rose 55.08% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (up 60.97% YoY) and the FY2025 annual result came in at $7.7 million, up 71.56% from the prior year.
• Share-based Compensation was $2.7 million for Q1 2026 at Korro Bio, up from $2.1 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $5.6 million in Q3 2022 and bottomed at -$14.3 million in Q4 2022.
• A 5-year average of $1.1 million and a median of $1.4 million in 2024 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation sank 376.63% — and 2024, when it jumped 215.1%.
• Korro Bio's Share-based Compensation stood at -$14.3 million in 2022, then jumped by 108.59% to $1.2 million in 2023, then rose by 10.59% to $1.4 million in 2024, then jumped by 52.62% to $2.1 million in 2025, then surged by 31.87% to $2.7 million in 2026.
• Business Quant data shows KRRO's Share-based Compensation at $2.7 million in Q1 2026, $2.1 million in Q4 2025, and $1.8 million in Q3 2025.